Skip to content

Comparison of bispectral index(BIS) change and clinical signs of awakening during sugammadex reversal of neuromuscular block according to the depth of propofol-remifentanil anesthesia

Comparison of bispectral index(BIS) change and clinical signs of awakening during sugammadex reversal of neuromuscular block according to the depth of propofol-remifentanil anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006248
Enrollment
66
Registered
2021-06-11
Start date
2021-11-09
Completion date
Unknown
Last updated
2023-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : When skin suturing begins, maintain the BIS in a steady state until the end of the surgery as follows. 1. Deep general anesthesia group: BIS 30±5 maintenance 2. Shallow general anesthesia g

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patents who have American society of anesthesiologist physical status I to III 2) Patients who are planned to undergo elective major abdominal surgery using propofol-remifentanil anesthesia taking one hour or more.

Exclusion criteria

Exclusion criteria: 1) Pediatric patient at or under 18. 2) Body Mass Index > 35 kg / m 2 or <18.5 kg / m 2 3) Severe liver disease 4) Severe kidney disease (GRF <30 or under hemodialysis) 5) Neuromuscular disease or mental illness 6) Those diagnosed with metabolic diseases 7) Drug addiction or alcohol addiction 8) Emergency surgery 9) Pregnant women or nursing women 10) People who have contraindications to muscle relaxants and sugammadex - Patients who have allergies to drugs or have a history of hypersensitivity reactions, respiratory disease patients, arrhythmia patients

Design outcomes

Primary

MeasureTime frame
Clinical sign of arousal (eye opening, cough, spontaneous movements, response to simple commands, complete recovery)

Secondary

MeasureTime frame
The change in BIS value after the sugammadex administration;The change in BIS-EMG value after the sugammadex administration;awake or recall during the surgery

Countries

Korea, Republic of

Contacts

Public Contactjeayoun kim

Samsung Medical Center

kimjy0705@naver.com+82-2-3410-6580

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 7, 2026